
Sign up to save your podcasts
Or


In this episode of 40s Forward, Dr. Betsy Greenleaf unpacks a bold statement she's made on social media: "Hormones are banned." Not because they're banned today — but because we may be heading down that road if hormones keep getting treated like a trendy quick fix instead of a medical tool that requires real expertise, monitoring, and whole-person care.
Dr. Greenleaf breaks down how fear around hormone therapy traces back to the Women's Health Initiative (WHI) era, how media messaging shaped decades of misunderstanding, and why today's surge in online hormone access + undertrained prescribing could lead to a knee-jerk regulatory crackdown. Bottom line: hormones can be life-changing — but misused hormones can harm patients and threaten access for everyone.
In this episode, we cover: • What "Hormones are banned" really means (and why it matters) • How the WHI created decades of hormone fear • The difference between non-natural hormones vs hormones naturally found in the body • Why estrogen + progesterone became the headline • Patents, profits, and the business forces behind hormone products • The "menopause marketplace" (and marketing manipulation) • Online hormone prescribing with minimal evaluation • Why hormones are a tool — not a cure-all • How misuse could trigger FDA overcorrection
The WHI Backlash (why it still echoes): • Fear exploded after WHI-era headlines • Later analysis highlighted major limitations (older population, formulation choices, and confusion between hormone types/delivery) • The cultural takeaway became: "hormones cause cancer/heart disease" • Result: patients and clinicians became afraid to even discuss HRT
Bioidentical/Bioequivalent hormones + the research gap: • Naturally occurring hormones are harder to patent • Less patent potential = fewer big research dollars • Big organizations stay cautious without large trials • Many guidelines default to "lowest dose, shortest time" messaging • Dr. Greenleaf emphasizes: balance + context matters more than fear
Menopause is mainstream… and business is watching: • Gen X is demanding options and refusing to "just suffer" • A marketplace explosion followed: menopause-labeled products, rebrands, and trend-based selling • The consumer challenge: separating real support from hype
The Hormone "Wild West" problem:
Direct-to-consumer hormone companies • Hormones without a real doctor-patient relationship • Minimal education, poor follow-up • Dosing that can be too high, too low, or wrong
Undertrained prescribing + conflicted training models • Clinicians entering hormones without adequate education • Some pellet training models include built-in incentives to overtreat • Patients end up "out of whack" and conclude "hormones don't work"
Why misuse could lead to restrictions: • Hormones become widely used • Mismanagement increases complications and poor outcomes • Regulators see correlation and respond with restriction • The tool gets taken away from trained clinicians and the patients who truly benefit Analogy: tools aren't dangerous — misuse is (gasoline in the wrong tank, driving with the parking brake on).
Key safety point: hormones must be balanced • Hormones work as a system — not isolated "fixes" • Testosterone can convert to estrogen • In a woman with a uterus, unopposed estrogen exposure increases risk of endometrial overgrowth • Progesterone can play a protective role for the uterine lining in appropriate candidates • OTC hormones like DHEA can convert downstream and still have real physiologic effects "Over-the-counter" does not mean "risk-free."
What patients should demand: • A practitioner who understands hormones as ONE tool within whole-body care • A plan that addresses the foundations that determine hormone response: Sleep • Hydration • Nutrition/inflammation • Stress • Gut microbiome • Environmental toxins/endocrine disruptors • Ongoing monitoring and individualized adjustments
Who this episode is for: • Women considering hormone therapy in peri/menopause • Men exploring hormone optimization and andropause • Anyone getting hormones online with little guidance • Patients who tried hormones and felt worse or "off" • Clinicians who want to do this correctly
Resources & Next Steps: Learn more about precision hormone care + whole-body optimization: PauseInstitute.com Pelvic and sexual wellness tools: Pelvic Floor Store Integrative wellness support: Greenleaf Nutraceuticals
Key Quote: "Hormones are a tool — not a panacea." If this episode made you think differently about hormone therapy, share it with a friend who's considering hormones (or already on them). Follow 40s Forward and keep the conversation going — because informed, responsible hormone care protects access for everyone.
By Dr. Betsy GreenleafIn this episode of 40s Forward, Dr. Betsy Greenleaf unpacks a bold statement she's made on social media: "Hormones are banned." Not because they're banned today — but because we may be heading down that road if hormones keep getting treated like a trendy quick fix instead of a medical tool that requires real expertise, monitoring, and whole-person care.
Dr. Greenleaf breaks down how fear around hormone therapy traces back to the Women's Health Initiative (WHI) era, how media messaging shaped decades of misunderstanding, and why today's surge in online hormone access + undertrained prescribing could lead to a knee-jerk regulatory crackdown. Bottom line: hormones can be life-changing — but misused hormones can harm patients and threaten access for everyone.
In this episode, we cover: • What "Hormones are banned" really means (and why it matters) • How the WHI created decades of hormone fear • The difference between non-natural hormones vs hormones naturally found in the body • Why estrogen + progesterone became the headline • Patents, profits, and the business forces behind hormone products • The "menopause marketplace" (and marketing manipulation) • Online hormone prescribing with minimal evaluation • Why hormones are a tool — not a cure-all • How misuse could trigger FDA overcorrection
The WHI Backlash (why it still echoes): • Fear exploded after WHI-era headlines • Later analysis highlighted major limitations (older population, formulation choices, and confusion between hormone types/delivery) • The cultural takeaway became: "hormones cause cancer/heart disease" • Result: patients and clinicians became afraid to even discuss HRT
Bioidentical/Bioequivalent hormones + the research gap: • Naturally occurring hormones are harder to patent • Less patent potential = fewer big research dollars • Big organizations stay cautious without large trials • Many guidelines default to "lowest dose, shortest time" messaging • Dr. Greenleaf emphasizes: balance + context matters more than fear
Menopause is mainstream… and business is watching: • Gen X is demanding options and refusing to "just suffer" • A marketplace explosion followed: menopause-labeled products, rebrands, and trend-based selling • The consumer challenge: separating real support from hype
The Hormone "Wild West" problem:
Direct-to-consumer hormone companies • Hormones without a real doctor-patient relationship • Minimal education, poor follow-up • Dosing that can be too high, too low, or wrong
Undertrained prescribing + conflicted training models • Clinicians entering hormones without adequate education • Some pellet training models include built-in incentives to overtreat • Patients end up "out of whack" and conclude "hormones don't work"
Why misuse could lead to restrictions: • Hormones become widely used • Mismanagement increases complications and poor outcomes • Regulators see correlation and respond with restriction • The tool gets taken away from trained clinicians and the patients who truly benefit Analogy: tools aren't dangerous — misuse is (gasoline in the wrong tank, driving with the parking brake on).
Key safety point: hormones must be balanced • Hormones work as a system — not isolated "fixes" • Testosterone can convert to estrogen • In a woman with a uterus, unopposed estrogen exposure increases risk of endometrial overgrowth • Progesterone can play a protective role for the uterine lining in appropriate candidates • OTC hormones like DHEA can convert downstream and still have real physiologic effects "Over-the-counter" does not mean "risk-free."
What patients should demand: • A practitioner who understands hormones as ONE tool within whole-body care • A plan that addresses the foundations that determine hormone response: Sleep • Hydration • Nutrition/inflammation • Stress • Gut microbiome • Environmental toxins/endocrine disruptors • Ongoing monitoring and individualized adjustments
Who this episode is for: • Women considering hormone therapy in peri/menopause • Men exploring hormone optimization and andropause • Anyone getting hormones online with little guidance • Patients who tried hormones and felt worse or "off" • Clinicians who want to do this correctly
Resources & Next Steps: Learn more about precision hormone care + whole-body optimization: PauseInstitute.com Pelvic and sexual wellness tools: Pelvic Floor Store Integrative wellness support: Greenleaf Nutraceuticals
Key Quote: "Hormones are a tool — not a panacea." If this episode made you think differently about hormone therapy, share it with a friend who's considering hormones (or already on them). Follow 40s Forward and keep the conversation going — because informed, responsible hormone care protects access for everyone.